Cantourage Group SEFRA:HIGH 20 PS Ratio is 89.09 as of Jul. 08, 2026, which is 2765% above its 10-year median of 3.11. GuruFocus rates FRA:HIGH with a GF Score™ of 20/100. The stock has 4 warning signs investors should review. Among 952 Drug Manufacturers companies, Cantourage Group SE ranks worse than 97.37% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Cantourage Group SE's share price is €5.88.
Cantourage Group SE's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2025 was €0.07. Hence, Cantourage Group SE's PS Ratio for today is 89.09.
Warning Sign:
Cantourage Group SE stock PS Ratio (=3.07) is close to 1-year high of 3.34.
The historical rank and industry rank for Cantourage Group SE's PS Ratio or its related term are showing as below:
FRA:HIGH'
s PS Ratio Range Over the Past 10 Years
Min: 1.22 Med: 3.11 Max: 273.33
Current: 89.09
During the past 5 years, Cantourage Group SE's highest PS Ratio was 273.33. The lowest was 1.22. And the median was 3.11.
FRA:HIGH's PS Ratio is ranked worse than 97.37% of 952
companies
in the Drug Manufacturers industry
Industry Median: 2.29
vs FRA:HIGH: 89.09
During the past 5 years, Cantourage Group SE's highest 3-Year average Revenue per Share Growth Rate was 252.90% per year. The lowest was 252.90% per year. And the median was 252.90% per year.
Back to Basics: PS Ratio
Cantourage Group SE (FRA:HIGH) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Cantourage Group SE PS Ratio Related Terms
Cantourage Group SE PS Ratio Historical Data
* Premium members only.
The historical data trend for Cantourage Group SE's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Cantourage Group SE's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cantourage Group SE PS Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Cantourage Group SE's PS Ratio distribution charts can be found below:
* The bar in red indicates where Cantourage Group SE's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Cantourage Group SE's Share Price of today is €5.88.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Cantourage Group SE's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2025 was €0.07.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Cantourage Group SE (FRA:HIGH) has a PS Ratio of 89.09 as of Jul. 08, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Cantourage Group SE and its competitors. This is 2765% above median its historical median of 3.11. Over the past decade, Cantourage Group SE's PS Ratio has ranged from 1.22 to 273.33. According to the industry distribution chart, Cantourage Group SE ranks #927 out of 952 companies in the Drug Manufacturers industry, placing it in the top 97.4%.
Is Cantourage Group SE's PS Ratio too high?
Cantourage Group SE's current PS Ratio of 89.09 is 2765% above median its 10-year median of 3.11. Over the past 10 years, this metric has ranged from a low of 1.22 to a high of 273.33. The Drug Manufacturers industry median PS Ratio is 2.29. Cantourage Group SE's value of 89.09 is 3790.4% above this industry median. Based on the distribution chart, Cantourage Group SE ranks #927 out of 952 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Cantourage Group SE has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Cantourage Group SE's PS Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Cantourage Group SE ranks #927 out of 952 companies for PS Ratio. This places Cantourage Group SE in the lower half of its industry. The industry median PS Ratio is 2.29. Cantourage Group SE's value of 89.09 is 3790.4% above this benchmark. Historically, Cantourage Group SE's own PS Ratio has ranged from 1.22 to 273.33 over the past decade. While the company's 10-year median is 3.11 vs. the industry median of 2.29, Cantourage Group SE has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Drug Manufacturers company?
The median PS Ratio among Drug Manufacturers companies is 2.29, based on 952 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cantourage Group SE's current PS Ratio of 89.09 is 3790.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Cantourage Group SE and its competitors. For the Drug Manufacturers industry, the median PS Ratio is 2.29 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cantourage Group SE's current PS Ratio is 89.09, which is 2765% above median its own 10-year median of 3.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cantourage Group SE stock overvalued right now?
Cantourage Group SE (FRA:HIGH) has a current PS Ratio of 89.09. The current PS Ratio is 89.09, which is 2765% above median its 10-year median of 3.11 and 3790.4% above the Drug Manufacturers industry median of 2.29. Cantourage Group SE's overall GF Score™ is 20/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Cantourage Group SE (FRA:HIGH), the current PS Ratio is 89.09 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Cantourage Group SE is engaged in the manufacture and wholesale of medicinal preparations based on cannabis and the trade and distribution of other legally permissible cannabis products, medical devices, pharmaceuticals, and accessories. The group offers cannabis flowers, dronabinol, CBD, and extracts of various strains.
20GF Score
Get the complete analysis for FRA:HIGH
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:HIGH has been successfully added to your 
